SLC1A1 and Parkinson disease: Previous studies have found out that EAAT3 dysfunction may lead to neuropsychiatric diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease, epilepsy, and schizophrenia [8,9,10,11,12,13].